Mineral metabolism abnormalities, such as low 1,25-dihydroxyvitamin D (1,25(OH) 2 D) and elevated parathyroid hormone (PTH), are common at even higher glomerular filtration rate than previously described. Levels of 25-hydroxyvitamin D (25(OH)D) show an inverse correlation with those of intact PTH and phosphorus. Studies of the general population found much higher allcause and cardiovascular (CV) mortality for patients with lower levels of vitamin D; this finding suggests that low 25(OH)D level is a risk factor and predictive of CV events in patients without chronic kidney disease (CKD). 25(OH)D/1,25(OH)2D becomes deficient with progression of CKD. Additionally, studies of dialysis patients have found an association of vitamin D deficiency with increased mortality. Restoration of the physiology of vitamin D receptor activation should be essential therapy for CKD patients.
Introduction
Vitamin D is known to be essential for bone metabolism.
The number of peer-reviewed publications with the term 'vitamin D' in their title or abstract has increased greatly since the early 2000s 1) . PubMed currently lists over 25, 000 publications from 1950 to the present. In the 1960s, fewer than 100 papers on 'vitamin D' were published per year; however, in 2010, this rate of publication reached approximately 2,500 papers per year. This expansion of research over recent decades has resulted in a dramatic increase in our understanding of additional biological actions of vitamin D on various systems including pancreas β-cell function, immune, cardiovascular, muscle, and brain systems, and control of the cell cycle. An interesting relationship exists between mortality in ischemic heart disease and geographic latitude in European countries 2) , which shows an increase in the mortality of heart retention and decrease in 1,25(OH) 2 Plain X-ray images of pelvis, hands, and lateral lumbar spines from all subjects were studied for calculation of semiquantitative vascular calcification scores, as described by Adragao 6) and Kauppila 7) . .
Vitamin D and vitamin D receptor
Vitamin D is a multifunctional hormone that can affect many essential biological functions, ranging from immune regulation to mineral ion metabolism. Calcitriol . VDR activation through these pathways has been shown to have wide-ranging effects. . In particular, vitamin D is closely linked to CVD 2) . Experimental studies have shown that vitamin D treatment reduces neurohormonal activation, inhibits inflammation, and suppresses ventricular hypertrophy 10) . . Hypovitaminosis D is prevalent even in patients with early-stage CKD 18) . . . In multivariate models, compared with the highest quartile, being in the lowest quartile for 25 [OH]D levels (< 17.8 ng/mL) was associated with a 26%
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increased rate of all-cause mortality (mortality rate ratio, . Multivariate-adjusted hazard ratios (HRs) for patients with lower levels of 25(OH)D were two times higher for all-cause mortality and cardiovascular mortality 21) .
A meta-analysis of randomized controlled trials by
Autier and Gandini showed that intake of ordinary doses of vitamin D supplements appears to be associated with decreases in total mortality rates 22) . They have identified . Among observational studies and randomized controlled trials, significant improvement was observed in serum 25(OH)D levels, along with an associated decline in PTH levels 23) . A low incidence of hypercalcemia and hyperphosphatemia has been reported with vitamin D supplementation. However, included studies were mostly of low to moderate quality and did not show beneficial effects on hard clinical endpoints 23) . Kovesdy et al. reported on the benefit of activated vitamin D treatment in patients with predialysis CKD 24) . Two hundred fifty-eight of 520 subjects received treatment with calcitriol. The incidence rate for mortality and combined death and dialysis initiation was significantly lower in treated than in untreated patients.
Treatment with calcitriol was associated with a trend toward a lower incidence of dialysis. These results were consistent across different subgroups 24) .
One prospective cohort study of incident dialysis patients in the Netherlands (the NECOSAD) revealed an (Table 2) .
Summary
In summary, vitamin D deficiency is common not only in CKD patient but also in the general population.
Reduced VDR activation occurs early in CKD. Low 
